Sökning: id:"swepub:oai:DiVA.org:uu-484316" >
Updates for the dia...
Updates for the diagnosis and management of cardiac amyloidosis
-
- Gosciniak, Piotr (författare)
- Pomeranian Med Univ, Tomasz Sokolowski Publ Hosp, Lab Noninvas Cardiac Imaging, Szczecin, Poland.;Pomeranian Med Univ, Dept Endocrinol Metab & Internal Dis, Szczecin, Poland.
-
- Baron, Tomasz (författare)
- Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Kardiologi,Centre for Medical Imaging, Uppsala University Hospital
-
- Milczarek, Slawomir (författare)
- Pomeranian Med Univ, Tomasz Sokolowski Publ Hosp, Dept Bone Marrow Transplantat, Hematol & Transplantol Clin, Szczecin, Poland.
-
visa fler...
-
- Kostkiewicz, Magdalena (författare)
- Jagiellonian Univ Med Coll, John Paul II Hosp, Dept Cardiovasc Dis, Krakow, Poland.;Jagiellonian Univ Med Coll, John Paul II Hosp, Dept Nucl Med, Krakow, Poland.
-
- Machalinski, Boguslaw (författare)
- Pomeranian Med Univ, Tomasz Sokolowski Publ Hosp, Dept Bone Marrow Transplantat, Hematol & Transplantol Clin, Szczecin, Poland.
-
visa färre...
-
Pomeranian Med Univ, Tomasz Sokolowski Publ Hosp, Lab Noninvas Cardiac Imaging, Szczecin, Poland;Pomeranian Med Univ, Dept Endocrinol Metab & Internal Dis, Szczecin, Poland. Uppsala kliniska forskningscentrum (UCR) (creator_code:org_t)
- 2022-02-23
- 2022
- Engelska.
-
Ingår i: Advances in Clinical and Experimental Medicine. - : Wroclaw Medical University. - 1899-5276 .- 2451-2680. ; 31:2, s. 175-185
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://uu.diva-port... (primary) (Raw object)
-
https://advances.umw...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- A substantial increase in the interest in transthyretin cardiac amyloidosis (ATTR-CA) is a result of the constantly growing number of patients, the use of clear diagnostic protocols and the availability of the first selective drug for these patients. This has also raised the awareness of the disease among physicians of all specialties. The topic is particularly relevant to cardiologists, who use non-invasive multimodal imaging in their daily practice.The differential diagnosis of the causes of myocardial hypertrophy includes arterial hypertension, hypertrophic cardiomyopathy, aortic stenosis (AS), athletic heart syndrome, Fabry disease, and cardiac amyloidosis (CA). It turns out that in patients with myocardial hypertrophy >15 mm, amyloidosis is the most common cause of left ventricular (LV) hypertrophy. In parallel, CA is one of the most common infiltrative diseases leading to a clinical picture that may mimic heart failure with preserved ejection fraction (HFpEF).The accumulation of amyloid in the extracellular space impairs the diastolic function of the myocardium, which is observed as the restrictive cardiomyopathy phenotype. In advanced cases, the LV systolic function is also impaired. Moreover, protein deposits contribute to the disturbances of calcium metabolism and cell metabolism as well as to cardiotoxicity, leading to edema and damage to cardiomyocytes.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Nyckelord
- cardiomyopathy
- amyloidosis
- multimodal imaging
- tafamidis
- apical sparing
Publikations- och innehållstyp
- ref (ämneskategori)
- for (ämneskategori)
Hitta via bibliotek
Till lärosätets databas